CERT

Certara (CERT)

About Certara (CERT)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Details

Daily high

$9.61

Daily low

$9.14

Price at open

$9.56

52 Week High

$15.69

52 Week Low

$8.02

Market cap

1.5B

Dividend yield

0.00%

Volume

1.8M

Avg. volume

2.5M

P/E ratio

136.80

Certara News